Neuros Biotechnology
Pre Seed Round in 2025
Neuros Biotechnology is a biotechnology company focused on developing innovative therapies for Alzheimer's disease. It pioneers a holistic approach, addressing various aspects of lifestyle-related disease modification, and leverages a proprietary, human-derived mixed biologic called NB-Px. This biologic possesses unique neuro-regenerative properties, enabling it to target neuroplastic deficiency and cognitive decline, thereby potentially reversing the progression of Alzheimer's disease and mild cognitive impairment.
Novel Microdevices
Venture Round in 2025
Novel Microdevices, LLC is a medical device company that specializes in the development of handheld devices for molecular diagnostics. Founded in 2014 and headquartered in Annapolis, Maryland, the company has created the NOVEL DX device, which employs microfluidics technology to analyze raw biological samples at the point of care. This device delivers results in approximately 30 minutes, allowing healthcare professionals to achieve lab-quality diagnostics without the need for a traditional laboratory setting. Novel Microdevices caters to various sectors, including clinical diagnostics, biodefense, food safety, forensics, drug discovery, animal care, and agriculture, thus addressing a wide range of applications in health and safety.
Nurse Lynx
Pre Seed Round in 2025
Nurse Lynx is a healthcare services provider specializing in home care and staffing. It offers a range of services, including companion care, wound care, meal preparation, medication management, and personal grooming, to enhance clients' quality of life and promote independence. The company's approach is guided by evidence-based prevention strategies and a commitment to health equity, aiming to improve patient outcomes.
Impruvon Health
Seed Round in 2025
Impruvon Health focuses on enhancing the health and well-being of individuals with complex medication regimens, particularly those in home or long-term care settings. The company has developed a medical technology platform that automates medication management, addressing the needs of specific groups such as individuals with intellectual or developmental disabilities, those recovering from addiction, and veterans. Their platform features smart alerts, reminders, and live notifications to prevent unauthorized access to medications, thereby promoting safety and compliance. By streamlining the storage, administration, and record-keeping processes associated with medication, Impruvon Health aims to reduce errors, thefts, and overdoses, ultimately supporting individuals and their caregivers in maintaining independence and security.
NanoBioFAB
Pre Seed Round in 2025
NanoBioFAB is a company based in Frederick, Maryland, specializing in the development of wearable, smart healthcare and medical devices utilizing nanotechnology. Founded in 2015, the company produces innovative products such as iNose, a device that allows individuals to detect, track, and monitor their body’s skin vapor-print. This device connects wirelessly to mobile phones, enabling users to track their fat burning rate, assess the effectiveness of their exercise routines, and observe the long-term effects of their dietary choices on metabolic rates. Additionally, NanoBioFAB offers nanoprinting technology and artificial intelligence sensors aimed at enhancing telemedicine and personalized healthcare solutions. The company is dedicated to making advanced healthcare accessible and affordable for both people and pets.
PediaMetrix
Seed Round in 2023
PediaMetrix Inc. is a healthcare technology company based in Rockville, Maryland, founded in 2018 by a team of entrepreneurs and scientists from Johns Hopkins, NIH, and Oxford. The company specializes in developing a digital tool aimed at improving pediatric head measurement and monitoring. Its primary product, SoftSpot, is a mobile application that utilizes artificial intelligence and computer vision to provide accurate measurements of infants' head shapes and monitor their growth patterns. The app offers parents instant quantitative analysis and personalized repositioning instructions to address flat head syndrome while enabling pediatricians to access comprehensive data for effective clinical decision-making. PediaMetrix's mission is to enhance healthcare outcomes for children by facilitating early detection and management of cranial abnormalities, ultimately aiming to reduce healthcare costs and improve overall pediatric care.
Linshom is a healthcare technology company that develops wearable, FDA-cleared sensors for continuous, predictive respiratory monitoring at the patient's bedside or home. Their core product, an operating room quality respiratory profile, enables early detection of respiratory decline, reducing costly rapid response activations and ICU transfers, thereby improving patient outcomes and lowering healthcare costs.
NanoBioFAB
Pre Seed Round in 2023
NanoBioFAB is a company based in Frederick, Maryland, specializing in the development of wearable, smart healthcare and medical devices utilizing nanotechnology. Founded in 2015, the company produces innovative products such as iNose, a device that allows individuals to detect, track, and monitor their body’s skin vapor-print. This device connects wirelessly to mobile phones, enabling users to track their fat burning rate, assess the effectiveness of their exercise routines, and observe the long-term effects of their dietary choices on metabolic rates. Additionally, NanoBioFAB offers nanoprinting technology and artificial intelligence sensors aimed at enhancing telemedicine and personalized healthcare solutions. The company is dedicated to making advanced healthcare accessible and affordable for both people and pets.
Astek Diagnostics
Seed Round in 2023
Astek Diagnostics is a healthcare company that develops precision diagnostic technology aimed at improving the diagnosis and treatment of bacterial infections. The company has created a platform that assists physicians in prescribing the correct antibiotics for patients suffering from bacterial sepsis within one hour. Utilizing a single-use cartridge, Astek Diagnostics' device identifies bacterial infections in urine by measuring the oxygen consumption of bacterial species, significantly reducing the turnaround time for results. This innovative approach not only facilitates timely treatment but also helps combat antibiotic resistance through effective susceptibility testing.
Linshom
Venture Round in 2022
Linshom is a healthcare technology company that develops wearable, FDA-cleared sensors for continuous, predictive respiratory monitoring at the patient's bedside or home. Their core product, an operating room quality respiratory profile, enables early detection of respiratory decline, reducing costly rapid response activations and ICU transfers, thereby improving patient outcomes and lowering healthcare costs.
Lasarrus
Pre Seed Round in 2022
Lasarrus is a medical device company founded in 2013 and headquartered in Baltimore, Maryland. The company specializes in developing wearable devices aimed at enhancing the physical therapy experience for patients, particularly those with chronic obstructive pulmonary disease. Lasarrus's innovative device facilitates remote monitoring and telemedicine by capturing physiological and range-of-motion data from various points on the body. This technology provides patients with an affordable, comfortable, and non-invasive means to track their health routines and accelerate their recovery process.
NanoBioFAB
Convertible Note in 2022
NanoBioFAB is a company based in Frederick, Maryland, specializing in the development of wearable, smart healthcare and medical devices utilizing nanotechnology. Founded in 2015, the company produces innovative products such as iNose, a device that allows individuals to detect, track, and monitor their body’s skin vapor-print. This device connects wirelessly to mobile phones, enabling users to track their fat burning rate, assess the effectiveness of their exercise routines, and observe the long-term effects of their dietary choices on metabolic rates. Additionally, NanoBioFAB offers nanoprinting technology and artificial intelligence sensors aimed at enhancing telemedicine and personalized healthcare solutions. The company is dedicated to making advanced healthcare accessible and affordable for both people and pets.
Medcura
Venture Round in 2022
Medcura, Inc. is a company that specializes in the development of advanced hemostatic products for various applications, including surgical, military, and consumer settings. Based in Riverdale, Maryland, Medcura has created a versatile wound care platform that utilizes abundant natural materials to produce innovative products for managing significant surgical bleeds. The company's offerings, marketed under brand names such as R3, Medcura Flex, LifeFoam, and Surgicura, include solutions that not only control bleeding but also provide antibacterial barriers, promoting enhanced healing environments. Founded in 2007 and rebranded from gel-e, Inc. in December 2019, Medcura aims to improve bleeding management in both clinical and non-clinical scenarios.
Tomorrow's Bio Today
Grant in 2022
Tomorrow's Bio Today is a developer of innovative medical devices designed for veterinary use, specifically targeting large animals such as cows and horses. The company specializes in ingestible tablet cameras that capture images of the gastrointestinal tracts of these animals. This technology transmits the collected images to a mobile application, offering a safer, more cost-effective, and comprehensive alternative to traditional endoscopic procedures. By enhancing the methods available for internal examinations, Tomorrow's Bio Today aims to assist healthcare professionals in diagnosing conditions like early-stage colorectal cancer in large animals, ultimately benefiting veterinarians and farmers through improved diagnostic capabilities.
Patient Premier
Grant in 2022
Patient Premier, Inc. is a medical software-as-a-service provider that specializes in developing a mobile platform for monitoring and documenting pain management adherence and efficacy. The company's flagship product, Pain Scored, enables individuals to track their health and share insights with healthcare professionals through self-reported assessments. This platform facilitates remote data collection between patient visits, allowing providers to review reports and coordinate care more effectively. Additionally, Patient Premier's solution permits healthcare providers to document and bill for time spent on care coordination, supporting proactive health management and chronic disease oversight. By utilizing standardized assessments, Patient Premier enhances the understanding of patients' pain, activity, and mood, ultimately improving health outcomes while reducing care costs. Founded in 2017 and based in Baltimore, Maryland, the company serves a diverse clientele, including individuals, healthcare providers, health systems, and insurers.
Dynamhex operates an emission monitoring platform that provides detailed insights into energy consumption data for individuals, corporations, and government entities. The platform enables users to measure their emission footprints and develop effective reduction strategies aligned with science-based targets. By employing geospatial analytics and advanced visualization techniques, Dynamhex helps city governments and businesses make informed, environmentally responsible decisions. This functionality supports climate leaders in their efforts to combat climate change by facilitating timely and data-driven decision-making.
BLOCKsyncop is a company focused on developing innovative clinical monitoring devices aimed at enhancing anesthesiology practices. Its primary product is a non-invasive, real-time tool designed to objectively measure and quantify the effectiveness of neural blocks for pain management. This technology assists anesthesiologists in reducing the occurrence of failed neural blocks, minimizing anesthetic toxicity, and optimizing the analgesic requirements for patients. By providing precise data, BLOCKsyncop aims to improve patient outcomes in pain management and support healthcare professionals in delivering safer and more effective anesthesia care.
PediaMetrix
Seed Round in 2021
PediaMetrix Inc. is a healthcare technology company based in Rockville, Maryland, founded in 2018 by a team of entrepreneurs and scientists from Johns Hopkins, NIH, and Oxford. The company specializes in developing a digital tool aimed at improving pediatric head measurement and monitoring. Its primary product, SoftSpot, is a mobile application that utilizes artificial intelligence and computer vision to provide accurate measurements of infants' head shapes and monitor their growth patterns. The app offers parents instant quantitative analysis and personalized repositioning instructions to address flat head syndrome while enabling pediatricians to access comprehensive data for effective clinical decision-making. PediaMetrix's mission is to enhance healthcare outcomes for children by facilitating early detection and management of cranial abnormalities, ultimately aiming to reduce healthcare costs and improve overall pediatric care.
NanoBioFAB is a company based in Frederick, Maryland, specializing in the development of wearable, smart healthcare and medical devices utilizing nanotechnology. Founded in 2015, the company produces innovative products such as iNose, a device that allows individuals to detect, track, and monitor their body’s skin vapor-print. This device connects wirelessly to mobile phones, enabling users to track their fat burning rate, assess the effectiveness of their exercise routines, and observe the long-term effects of their dietary choices on metabolic rates. Additionally, NanoBioFAB offers nanoprinting technology and artificial intelligence sensors aimed at enhancing telemedicine and personalized healthcare solutions. The company is dedicated to making advanced healthcare accessible and affordable for both people and pets.
PediaMetrix
Seed Round in 2021
PediaMetrix Inc. is a healthcare technology company based in Rockville, Maryland, founded in 2018 by a team of entrepreneurs and scientists from Johns Hopkins, NIH, and Oxford. The company specializes in developing a digital tool aimed at improving pediatric head measurement and monitoring. Its primary product, SoftSpot, is a mobile application that utilizes artificial intelligence and computer vision to provide accurate measurements of infants' head shapes and monitor their growth patterns. The app offers parents instant quantitative analysis and personalized repositioning instructions to address flat head syndrome while enabling pediatricians to access comprehensive data for effective clinical decision-making. PediaMetrix's mission is to enhance healthcare outcomes for children by facilitating early detection and management of cranial abnormalities, ultimately aiming to reduce healthcare costs and improve overall pediatric care.
Vixiar Medical, established in 2013 and headquartered in Annapolis, Maryland, specializes in developing non-invasive, cost-effective devices and systems for monitoring cardiopulmonary diseases. Its flagship product, Indicor, is a handheld point-of-care device and digital platform designed to monitor and manage worsening heart failure. Vixiar's devices aim to enhance clinical workflow and deliver economic value to the healthcare system by enabling monitoring in various settings, including homes, offices, nursing homes, and hospitals.
NanoBioFAB is a company based in Frederick, Maryland, specializing in the development of wearable, smart healthcare and medical devices utilizing nanotechnology. Founded in 2015, the company produces innovative products such as iNose, a device that allows individuals to detect, track, and monitor their body’s skin vapor-print. This device connects wirelessly to mobile phones, enabling users to track their fat burning rate, assess the effectiveness of their exercise routines, and observe the long-term effects of their dietary choices on metabolic rates. Additionally, NanoBioFAB offers nanoprinting technology and artificial intelligence sensors aimed at enhancing telemedicine and personalized healthcare solutions. The company is dedicated to making advanced healthcare accessible and affordable for both people and pets.
Linshom
Seed Round in 2017
Linshom is a healthcare technology company that develops wearable, FDA-cleared sensors for continuous, predictive respiratory monitoring at the patient's bedside or home. Their core product, an operating room quality respiratory profile, enables early detection of respiratory decline, reducing costly rapid response activations and ICU transfers, thereby improving patient outcomes and lowering healthcare costs.
Aperio Health
Seed Round in 2017
Aperio Health develops comprehensive software solutions for healthcare enterprises. Their technology integrates multiple functionalities into a single platform, facilitating multi-channel care delivery. This platform enables healthcare providers to efficiently manage current delivery and reimbursement models, adapt to evolving population health management needs, and deliver cost-effective care tailored to community-based settings.
Vixiar Medical, established in 2013 and headquartered in Annapolis, Maryland, specializes in developing non-invasive, cost-effective devices and systems for monitoring cardiopulmonary diseases. Its flagship product, Indicor, is a handheld point-of-care device and digital platform designed to monitor and manage worsening heart failure. Vixiar's devices aim to enhance clinical workflow and deliver economic value to the healthcare system by enabling monitoring in various settings, including homes, offices, nursing homes, and hospitals.
Sonavex, Inc. is a medical technology company based in Baltimore, Maryland, founded in 2013. The company specializes in developing innovative imaging solutions, primarily focusing on ultrasound-based methods to detect anastomotic blood clots and assess vascular health. Sonavex's proprietary technology platform provides clinicians with real-time visualization of critical data at the point of care, enabling them to measure intravascular flow metrics and detect post-operative clots effectively. Additionally, the company has developed bioresorbable and echogenic equipment designed to mark at-risk blood vessels, allowing for future assessments of complications. This technology collects essential data, such as volumetric flow rate and vessel morphology, to enhance patient care in surgical settings, ultimately aiming to improve outcomes for surgical patients.
Cordex Systems
Series A in 2017
Cordex Systems designs and manufactures a cardiovascular diagnostic device. Its product includes the Cordex EnDys System is a diagnostic tool that provides both early detection and ongoing monitoring of cardiovascular disease by measuring endothelial dysfunction.
Untethered Labs
Convertible Note in 2016
Untethered Labs, Inc. is a technology company based in College Park, Maryland, founded in 2015. It specializes in developing wireless security solutions for the enterprise security and access control markets. The company's flagship product, GateKeeper, is a Bluetooth-based keyfob that automatically locks and unlocks a user's computer based on proximity. This innovation addresses critical needs for hardware-based authentication and privacy, making it particularly valuable for industries such as healthcare, which must comply with HIPAA regulations, as well as for large organizations that prioritize data integrity and security. By providing modern access control solutions, Untethered Labs aims to enhance security protocols for both small and large enterprises.
Lazy Corporation specializes in quality measurement solutions for healthcare providers, focusing on simplifying the complexities associated with healthcare quality reporting. The company offers a physician quality reporting program that facilitates registry-based measures, allowing users to capture data seamlessly through web, iPad, or mobile applications. Additionally, Lazy provides consulting services to assist clients in implementing electronic Clinical Quality Measures (eCQM) and developing and testing eCQM specifications. By addressing the challenges of data collection, reporting requirements, and adherence to various measure specifications and guidelines, Lazy enables healthcare organizations to effectively manage and track their quality measurement initiatives. Based in Washington, D.C., the company is committed to improving healthcare quality assurance through innovative solutions and expert guidance.
Avhana Health
Seed Round in 2014
Avhana Health Inc., established in 2014 and based in Baltimore, Maryland, specializes in streamlining healthcare provider workflows through its application. This platform integrates with electronic health records (EHR) to deliver real-time, patient-specific clinical recommendations, actionable guidelines, and performance metrics directly within the EHR interface. The software facilitates pre-visit planning, suggests relevant orders that can be submitted directly into the EHR, and tracks provider activity for performance evaluation. Avhana Health's mission is to empower healthcare teams with impactful, patient-specific support to enhance care quality and reduce costs.
Noble Life Sciences
Seed Round in 2014
Noble Life Sciences is a contract research organization based in Gaithersburg, Maryland, founded in 2010. It specializes in providing preclinical drug development services to the biotech, pharmaceutical industries, and academia. The company offers a range of services including disease and animal models, drug pharmacology, exploratory toxicology, oncology drug evaluation, and custom polyclonal antibodies. Additionally, Noble Life Sciences provides vivarium services for small animals, regulatory oversight, veterinary care, breeding, husbandry, technical support, and protocol review. It also supports the development of medical devices through testing services for orthopedics, cardiovascular, trauma, and wound healing applications. The company's state-of-the-art laboratory facility and experienced staff ensure high-quality preclinical contract services, aiding in the efficient transition from concept to clinic.
Ariadne Diagnostics
Seed Round in 2014
Ariadne Diagnostics, LLC is a molecular diagnostic company based in Rockville, Maryland, focused on the discovery and development of companion diagnostic tests for oncology and rare neuromuscular and neurodegenerative diseases. Established in 2011, the company leverages advanced bioinformatics tools to integrate genomic, proteomic, cellular, and clinical data for selecting candidate biomarkers that can predict individual patient responses to drug therapies. Notable offerings include a predictive screening test for metastatic colorectal cancer, along with contract research and biomarker program support services encompassing biomarker discovery, assay development and validation, and clinical studies. Ariadne Diagnostics combines extensive expertise in bioinformatics and clinical assay development to address unmet medical needs in precision medicine.
Clym Environmental Services., Llc.
Clym Environmental Services provides waste management & environmental, health & safety services to healthcare industries.
The LaunchPort, established in 2018 in Baltimore, Maryland, operates as an incubator focused on the healthcare sector. The company provides a comprehensive suite of services designed to support startups and established businesses in their development processes. These services include layout and location assistance, manufacturing and prototyping, engineering, sterilization, and access to clean rooms. Additionally, The LaunchPort offers core operational support services such as financial systems management, quality system development, supply chain activities, and regulatory compliance. They also facilitate reimbursement strategies and revenue model development. Beyond these services, The LaunchPort provides training, both group and individual, and offers access to corporate business advisors to refine business models.